U.S. Personal Products Stock News

NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

CFO Retirement And Interim Successor Put Focus On MPWR Valuation And Margins

Monolithic Power Systems (NasdaqGS:MPWR) announced the retirement of Chief Financial Officer and Executive Vice President Bernie Blegen after a decade in executive roles. Long-time Corporate Controller Rob Dean has been promoted to interim CFO, marking an internal succession within the finance team. The leadership change highlights a transition at the top of the company’s financial function while the board considers longer term plans for the role. Monolithic Power Systems focuses on analog...
NYSE:CNP
NYSE:CNPIntegrated Utilities

A Look At CenterPoint Energy’s Valuation As Grid Upgrades And Q4 2025 Earnings Come Into Focus

CenterPoint Energy (CNP) is in focus as it prepares to report fourth quarter 2025 results on February 19, alongside recent grid upgrades and the launch of its Community Progress Tracker in Greater Houston. See our latest analysis for CenterPoint Energy. Those grid upgrades and the new Community Progress Tracker arrive at a time when momentum in CenterPoint Energy’s share price has been building, with a 30 day share price return of 7.40% and a 1 year total shareholder return of 29.19% from a...
NYSE:PWR
NYSE:PWRConstruction

Is It Too Late To Consider Quanta Services (PWR) After Its Strong Multi‑Year Rally?

If you are wondering whether Quanta Services at around US$525 a share still offers value, you are not alone. This article is designed to help you assess that question clearly. The stock has recorded returns of 2.8% over the last 7 days, 12.5% over the last 30 days, 19.4% year to date and 82.8% over the past year, with a very large 5 year return that is well over 5x the starting point. This naturally raises questions about what is already priced in. Recent headlines around Quanta Services...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Waystar Integration Of Iodine And AI Recognition Reshape Growth Outlook

Waystar Holding (NasdaqGS:WAY) has rapidly integrated Iodine Software following its acquisition, completing key revenue cycle and clinical intelligence alignment ahead of schedule. The combined platform now reaches a larger hospital client base and is being recognized nationally for its AI driven revenue cycle automation. Waystar was recently named an Inc. Best in Business honoree for AI Implementation, highlighting its role in healthcare revenue cycle automation. Waystar's recent moves...
NYSE:FHI
NYSE:FHICapital Markets

A Look At Federated Hermes (FHI) Valuation As Shares Trade Near Fair Value Estimates

Federated Hermes (FHI) has drawn fresh attention after recent trading left the shares with a reported intrinsic discount of about 13%, prompting investors to reassess the asset manager’s valuation and long term return profile. See our latest analysis for Federated Hermes. Recent trading has been choppy, with the 1 day share price return of Federated Hermes at a 1% decline. However, the 90 day share price return of 14.24% and the 1 year total shareholder return of 46.58% point to building...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex (CGNX) Is Up 32.7% After Earnings Beat, Board Refresh And Completed Buybacks – Has The Bull Case Changed?

Cognex recently reported fourth-quarter 2025 sales of US$252.34 million and full-year sales of US$994.36 million, alongside higher net income and earnings per share, while completing a US$500 million share repurchase program and declaring a quarterly dividend of US$0.085 per share. On top of these capital returns, the Board refreshed its membership by appointing automation and enterprise sales veterans Dr. Sami Atiya and Chris Donato, changes that could influence how Cognex pursues AI-driven...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

How Investors May Respond To Interparfums (IPAR) Rising Estimates Amid Expectations Of Lower Earnings

Interparfums, the fragrance maker behind brands such as Kate Spade and Abercrombie & Fitch, recently attracted attention after analysts revised earnings estimates higher for the quarter ended December 2025, even as they anticipated earnings would decline year over year on higher revenue. This shift in expectations, alongside the company’s track record of 14.1% annual revenue growth over the past three years and strong returns on invested capital, has reinforced confidence in its ability to...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns?

If you are wondering whether LeMaitre Vascular at around US$89.25 is priced fairly or not, this article will walk through what the current valuation actually implies for you as a shareholder or potential investor. The stock shows a mix of recent returns, with gains of 1.4% over the last 7 days, 1.1% over 30 days and 11.3% year to date, but a 10.6% decline over 1 year, alongside longer term returns of 85.6% over 3 years and 98.2% over 5 years. Recent news coverage around LeMaitre Vascular has...
NYSE:DHR
NYSE:DHRLife Sciences

Is Danaher (DHR) Attractive After Recent Share Price Weakness?

If you are wondering whether Danaher at around US$206 per share still offers good value, you are not alone. The answer depends on how you look at its underlying business and valuation. The stock has recently been under pressure, with a 6.1% decline over the last week, a 12.6% decline over the last month and a 10.4% decline year to date, although the 1 year return sits at 1.5%. These moves sit against a backdrop of ongoing interest in large, diversified life sciences and diagnostics...
NYSE:S
NYSE:SSoftware

Is There Now An Opportunity In SentinelOne (S) After A 45% One Year Share Price Fall

If you are wondering whether SentinelOne's current share price reflects its true worth, this article will walk through what the numbers are really saying about the stock. After its last close at US$13.40, SentinelOne's returns sit at a 2.4% decline over 7 days, a 3.6% decline over 30 days, an 8.5% decline year to date, and a 45.0% decline over the past year, with a 12.5% decline over 3 years. Recent coverage of SentinelOne has focused on its position in cybersecurity and how investor...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

The Bull Case For Construction Partners (ROAD) Could Change Following Raised 2026 Guidance And Buybacks - Learn Why

Construction Partners, Inc. recently reported first-quarter 2026 results showing sales of US$809.47 million and net income of US$17.21 million, and it raised full-year fiscal 2026 revenue and net income guidance while also completing a US$22.94 million share repurchase program announced in April 2024. Alongside these financial updates, the company’s participation at the Barclays 43rd Annual Industrial Select Conference in Miami in February 2026 gave management an additional platform to...
NYSE:AB
NYSE:ABCapital Markets

AllianceBernstein Initiatives In Research And Tech Set Against Valuation Concerns

AllianceBernstein Holding (NYSE:AB) has entered a new joint venture with Societe Generale to build out global research capabilities. The firm is expanding further into private alternatives with capital support from EQH. AllianceBernstein has also signed a multi year partnership with SimCorp to upgrade its investment technology and data infrastructure. For investors watching NYSE:AB, these moves sit alongside a recent share price of $41.43 and multi year total returns of 21.9% over 1 year,...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

A Look At Atomera (ATOM) Valuation After GAA MST Breakthroughs And New OEM Partnership

Atomera (ATOM) is back on investors’ radar after reporting fourth quarter and full year 2025 results that highlight very small current sales, continued losses, and ongoing investment in its Mears Silicon Technology platform. See our latest analysis for Atomera. The latest earnings release and technical updates landed alongside a sharp shift in sentiment, with a 46.17% 1 day share price return and a 142.80% year to date share price return contrasting with a 5 year total shareholder return...
NYSE:STT
NYSE:STTCapital Markets

What State Street (STT)'s New Prime Money Market ETF and Mariner Deal Mean For Shareholders

In February 2026, State Street Corporation announced that Mariner will adopt Charles River’s Wealth Management Solution to support its goal of scaling from more than 2,080 advisors toward 5,000 while centralizing portfolio management, trading, data integration, and advisor workflows. State Street Investment Management also launched the actively managed State Street Prime Money Market ETF (ticker: MMK), a low-cost prime cash vehicle drawing on its cash team’s US$599.55 billion in assets...
NasdaqGS:PPC
NasdaqGS:PPCFood

Assessing Pilgrim's Pride (PPC) Valuation After Earnings Miss And 2026 Expansion Plan

Pilgrim's Pride (PPC) is back in focus after reporting fourth quarter 2025 earnings, with higher sales and softer margins, plus a sizable 2026 capex plan aimed at prepared foods capacity and operational efficiencies. See our latest analysis for Pilgrim's Pride. The latest earnings release and 2026 capex plan come after a period of firm momentum in the shares, with a 30 day share price return of 5.10% and a 90 day share price return of 15.61%. This is the case even though the 1 year total...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings Faces Rising Short Interest As Earnings Estimates Improve

Short interest in MARA Holdings (NasdaqCM:MARA) has recently moved sharply higher, now sitting well above levels seen in many peers. Analysts have turned more cautious on the stock, citing sector risks and increased insider selling activity. The shift in positioning comes even as some earnings estimates for MARA Holdings have been revised upward. MARA Holdings, listed on NasdaqCM under the ticker MARA, has attracted fresh attention as investor positioning has turned more bearish. The...
NYSE:DCH
NYSE:DCHAuto Components

Assessing Whether Dauch (DCH) Is Undervalued After Recent Share Price Volatility

Stock performance snapshot and recent context Dauch (DCH) has drawn attention after a period of mixed share performance, with a small 1 day gain of 0.41% contrasting with a roughly 14% decline over the past week. Over the past month the stock shows a decline of about 5%, while the past 3 months are positive at roughly 17%. Year to date, Dauch is up about 12%, with a 1 year total return of around 26%. See our latest analysis for Dauch. The latest 7 day share price return of around 14% decline...
NYSE:TROX
NYSE:TROXChemicals

Is It Time To Rethink Tronox Holdings (TROX) After Its Recent Share Price Surge

If you are wondering whether Tronox Holdings at around US$7.60 is a bargain or a value trap, looking closely at how the market is pricing the business is a good place to start. The share price has been volatile recently, with a 32.9% return over the last 30 days, a 78.0% return year to date, but only a 1.7% return over the past year and longer term declines of 41.8% over three years and 54.2% over five years. These swings have put Tronox back on the radar for investors comparing short term...
NYSE:BORR
NYSE:BORREnergy Services

Is Analyst Repricing And Q4 Guidance Shifting The Investment Case For Borr Drilling (BORR)?

Citigroup analyst Scott Gruber recently reiterated a Neutral rating on Borr Drilling and raised its price target, while the company released its Q4 2025 earnings today after previously signaling an expected earnings per share loss of $0.03. These developments highlight how analysts are closely tracking Borr Drilling’s contracting progress and financial outlook as they reassess expectations for its offshore drilling operations across multiple regions. We’ll now examine how the upcoming...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific Tests Combined Cardiac Devices In OPTION EMEA Trial

Boston Scientific (NYSE:BSX) has started the OPTION-EMEA clinical trial in real world hospital settings across Europe. The study evaluates the combined use of two cardiac devices for patients with atrial fibrillation and stroke prevention. The trial is designed to assess safety and potential benefits of this combined therapy approach in routine clinical practice. For investors watching NYSE:BSX, this new trial comes as the shares trade at $76.29. The stock is up 65.0% over the past 3 years...
NasdaqGS:ALGT
NasdaqGS:ALGTAirlines

Allegiant’s Destination Dollywood Flight Highlights Experiential Travel And Ancillary Upside

Allegiant Travel Company (NasdaqGS:ALGT) has launched a themed "Destination Dollywood" flight experience in partnership with Dollywood Parks & Resorts. The offering combines tailored in flight entertainment with bundled travel and resort packages tied to the Dollywood brand. The collaboration focuses on leisure travelers seeking packaged experiences that connect air travel with on the ground attractions. For Allegiant Travel, which focuses on leisure oriented, low cost flying, this type of...
NasdaqCM:DJCO
NasdaqCM:DJCOSoftware

Daily Journal (DJCO) Quarterly Loss Challenges Bullish Earnings Growth Narrative

Daily Journal's Q1 2026 Results In Focus Daily Journal (DJCO) opened fiscal 2026 with Q1 revenue of US$19.5 million and a basic EPS loss of US$5.79, against trailing 12 month EPS of US$67.70 on revenue of US$89.5 million, which has been influenced by a one off gain of US$109.2 million over the past year. The company has seen quarterly revenue move from US$17.7 million in Q1 2025 to US$19.5 million in Q1 2026, while trailing 12 month EPS has shifted from US$55.48 to US$67.70 and net income...
NYSE:BLSH
NYSE:BLSHCapital Markets

Will Ark Invest’s BitLicense-Era Buying Spree Change Bullish's (BLSH) Institutional Crypto Narrative?

In recent weeks, Ark Invest has steadily accumulated shares of cryptocurrency exchange Bullish, purchasing about US$58.75 million across ten consecutive trading days. This persistent buying coincides with Bullish securing a New York BitLicense and highlighting more than US$1.50 trillion in cumulative trading volume, underscoring its focus on large professional clients. Next, we’ll examine how Ark Invest’s repeated Bullish purchases shape the company’s investment narrative and perceived...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

Four Corners Property Trust Ramps Up Deals With Valuation Gap In Focus

Four Corners Property Trust (NYSE:FCPT) accelerated its acquisition activity in 2025, closing a large number of net lease deals. Management highlighted portfolio diversification and tenant mix as key priorities on the latest earnings call. The company emphasized disciplined underwriting and a focus on maintaining a strong balance sheet and conservative leverage. Four Corners Property Trust focuses on net lease properties, a part of real estate that often centers on long term tenant...